CD47 Biosimilar Antibody

SKU: orb689306

Description

Anti-CD47 (magrolimab biosimilar) mAb

Images & Validation

• Tested Applications: ELISA, FC
• Dilution range: ELISA 1:5000-10000 Flow Cyt 1:100
• Reactivity: Human
• Application Notes:
  Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution.

Key Properties

• Antibody Type: Biosimilar Antibody
• Host: Chimeric Humanized
• Clonality: Monoclonal
• Isotype: IgG4
• Target: CD47
• Purification: Purified from cell culture supernatant by affinity chromatography

Storage & Handling

• Storage: Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
• Form/Appearance: Powder
• Disclaimer: For research use only

Alternative Names

CD47MER6IAP

ELISA plate pre-coated by 2 μg/ml (100 μL/well) Human CD47, mFc-His tagged protein orb689369 can bind Anti-CD47 (Neutralizing antibody clone Hu5F9-G4) in a linear range of 0.061-1.606 ng/ml.

HEK293 cell line transfected with irrelevant protein (B) and human CD47 (A) were surface stained with anti-CD47 neutralizing antibody 1 μg/ml (magrolimab) followed by Alexa 488-conjugated anti-human IgG secondary antibody.

Quick Database Links

Gene Symbol

CD47

UniProt

Q08722

References

M Schwarzfischer, MR Walker, M Curcio, NM Boshta, A Marchand, E Soons, D Pöhlmann… Synthetic GPR84 Agonists in Colorectal Cancer: Effective in THP-1 Cells but Ineffective in BMDMs and MC38 Mouse Tumor Models International Journal of Molecular Sciences, (2025)

PubMed: